Cooper Creek Partners Management’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-78,170
Closed -$438K 148
2022
Q1
$438K Hold
78,170
0.05% 106
2021
Q4
$401K Hold
78,170
0.05% 107
2021
Q3
$330K Hold
78,170
0.04% 101
2021
Q2
$711K Buy
78,170
+39,973
+105% +$393K 0.18% 96
2021
Q1
$367K Buy
+38,197
New +$313K 0.1% 90

Other funds holding ALIM

Cooper Creek Partners Management's ALIM Position: Q2 2022 in Review

Cooper Creek Partners Management sold out of Alimera Sciences (ALIM) in Q2 2022, closing a stake of 78,170 shares — an estimated $438K sold.

Cooper Creek Partners Management first reported a position in ALIM in Q1 2021 and held it in 5 quarters. The position peaked at $711K in Q2 2021. 20 funds tracked by Wall St. Rank hold ALIM as of Q2 2022.

  • Cooper Creek Partners Management reported no remaining Alimera Sciences position as of Q2 2022 after selling out during the quarter.
  • Cooper Creek Partners Management sold 78,170 Alimera Sciences shares in Q2 2022, an estimated $438K.
  • Cooper Creek Partners Management first reported a position in Alimera Sciences in Q1 2021 and held it in 5 quarters.
  • Cooper Creek Partners Management's Alimera Sciences position peaked at $711K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2022.

Based on Cooper Creek Partners Management's 13F filing for Q2 2022, filed 15 Aug 2022.